-
The general trend of "double resistance"! Many MNCs, such as Aberdeen and Sanofi, have invested heavily in the layout
Time of Update: 2020-06-19
on June 9, Cinda biology announced a strategic R & D cooperation with Roche Group, focusing on research, clinical development and commercialization of multiple bispecific antibodies and cell therapy products.
-
List of new drugs approved by CDER in 2019! Novartis, Aberdeen, Genentech
Time of Update: 2020-06-19
In 2019, the FDA Center for drug review and Research (CDER) approved 48 new drugs, including 37 new molecular entities (NME) and 11 biological product licensing applications (BLA). Compared with 59 in 2018, the total number decreased by 11, down
-
Aberdeen announces positive results from viale-a (m15-656) study
Time of Update: 2020-06-19
Alberto announced the positive results of viale-a (m15-656) study. The results showed that venetoclax (venclexta or venclyxto) combined with azacytidine could reduce the risk of death by 34% compared with azacytidine combined with placebo (hazard
-
List of new drugs approved by CDER in 2019! Novartis, Aberdeen, Genentech, Trinity
Time of Update: 2020-01-02
In 2019, the FDA Center for drug review and Research (CDER) approved 48 new drugs, including 37 new molecular entities (NME) and 11 biological product licensing applications (BLA
-
Price rise again! Roche, Novartis, Lilly and Aberdeen will raise the price of 83 drugs this month
Time of Update: 2019-07-11
In a report, Wells Fargo analyst David Maris wrote that since July, pharmaceutical companies including Aberdeen, Roche's Genentech, Lilly, GlaxoSmithKline and Sanofi have increased the prices of at least 83 drugs.
-
[yaocajun] 5-pound bomb detonates the drug circle, Hengrui, hausen, Bayer, Pfizer and Aberdeen; new
Time of Update: 2019-05-13
However, Shuanglu and Zhengda Tianqing are approved according to the application of the old 3.1 new drugs and the old 6 generic drugs, which still need to pass the consistency evaluation.
-
Tragedy of Aberdeen, MSD / Johnson! EMA accepts the listing application of two bio generic drugs of Sandoz
Time of Update: 2017-06-01
Source: Sina pharmaceutical 2017-06-01 Sandoz, a generic unit of Novartis, recently announced that the European Drug Administration (EMA) has accepted the application for marketing
-
J & J's $1.1 billion acquisition of three anti HCV pipelines to beat Gillette and Aberdeen
Time of Update: 2015-05-26
According to the purchase agreement, the three products are ach-3102, an NS5A inhibitor, sovaprevir, an NS3 / 4A protease inhibitor, and ach-3422, an NS5B polymerase inhibitor, which are in phase I clinical phase.
-
Die for Johnson! Aberdeen's $21 billion marriage to pharmacyclics
Time of Update: 2015-03-06
Source: Biovalley 2015-03-05 March 5, 2015 news, the financial times (FT) just revealed that Johnson & Johnson is about to buy partner pharmacyclics with more than $17 billion
-
Google and Aberdeen work together to fight "death"
Time of Update: 2014-09-04
On September 4, Beijing time, calico, a subsidiary of Internet giant Google, and Alberto, a pharmaceutical giant, reached a cooperation in the field of aging disease treatment.
-
US $53.7 billion swallowing shire Aberdeen touches the nerve of US tax reverse transaction
Time of Update: 2014-07-22
Source: e-medicine Facebook on July 18, 2014, with the recommendation of the board of directors, shire shareholders finally agreed to accept the M & a invitation of Albright
-
US pharmaceutical giant Aberdeen's US $55 billion acquisition of shire
Time of Update: 2014-07-21
The offer represents a 53% premium to shire's share price on May 2, the time when the company first proposed a merger.
-
How does Susan Kilsby manipulate the acquisition of shire by Aberdeen?
Time of Update: 2014-07-17
In a telephone interview, Scott Lindsay, head of M & A at Credit Suisse in New York, told Bloomberg that Kilsby's M & a skills had made Alberto bid five times without giving up the negotiation.
